Drug Type Small molecule drug |
Synonyms TLI-1026, Dextrogol |
Mechanism CACNA2D2 blockers(Voltage-gated calcium channel alpha2/delta subunit 2 blockers), Cav2.2 blockers(Voltage-gated N-type calcium channel alpha-1B subunit blockers), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H28BrNO2 |
InChIKeySTTADZBLEUMJRG-IKNOHUQMSA-N |
CAS Registry6700-34-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibromyalgia | Phase 1 | - | - |